Swiss National Bank Amneal Pharmaceuticals, Inc. Transaction History
Swiss National Bank
- $150 Billion
- Q3 2024
A detailed history of Swiss National Bank transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 242,100 shares of AMRX stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
242,100
Previous 242,100
-0.0%
Holding current value
$2.01 Million
Previous $1.54 Million
31.03%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
140MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$181 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$122 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$102 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.8 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.1 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.26B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...